BLUE BIRD CORP (BLBD)

US0953061068 - Common Stock

53.82  -0.81 (-1.48%)

After market: 53.82 0 (0%)

Fundamental Rating

5

BLBD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 130 industry peers in the Machinery industry. BLBD has an average financial health and profitability rating. BLBD is not valued too expensively and it also shows a decent growth rate.



5

1. Profitability

1.1 Basic Checks

In the past year BLBD was profitable.
BLBD had a positive operating cash flow in the past year.
In multiple years BLBD reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: BLBD reported negative operating cash flow in multiple years.

1.2 Ratios

BLBD has a Return On Assets of 17.57%. This is amongst the best in the industry. BLBD outperforms 95.31% of its industry peers.
With an excellent Return On Equity value of 75.80%, BLBD belongs to the best of the industry, outperforming 99.22% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 33.82%, BLBD belongs to the top of the industry, outperforming 99.22% of the companies in the same industry.
Industry RankSector Rank
ROA 17.57%
ROE 75.8%
ROIC 33.82%
ROA(3y)-2.3%
ROA(5y)0.72%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BLBD has a Profit Margin (6.36%) which is comparable to the rest of the industry.
BLBD's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.72%, BLBD is in line with its industry, outperforming 51.56% of the companies in the same industry.
In the last couple of years the Operating Margin of BLBD has grown nicely.
The Gross Margin of BLBD (17.69%) is worse than 74.22% of its industry peers.
In the last couple of years the Gross Margin of BLBD has remained more or less at the same level.
Industry RankSector Rank
OM 9.72%
PM (TTM) 6.36%
GM 17.69%
OM growth 3Y22.15%
OM growth 5Y5.9%
PM growth 3Y14.85%
PM growth 5Y-5.7%
GM growth 3Y3.86%
GM growth 5Y0.59%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLBD is creating value.
Compared to 1 year ago, BLBD has more shares outstanding
Compared to 5 years ago, BLBD has more shares outstanding
Compared to 1 year ago, BLBD has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 6.79 indicates that BLBD is not in any danger for bankruptcy at the moment.
BLBD has a better Altman-Z score (6.79) than 86.72% of its industry peers.
The Debt to FCF ratio of BLBD is 0.82, which is an excellent value as it means it would take BLBD, only 0.82 years of fcf income to pay off all of its debts.
BLBD has a better Debt to FCF ratio (0.82) than 91.41% of its industry peers.
BLBD has a Debt/Equity ratio of 0.88. This is a neutral value indicating BLBD is somewhat dependend on debt financing.
BLBD has a Debt to Equity ratio of 0.88. This is amonst the worse of the industry: BLBD underperforms 80.47% of its industry peers.
Even though the debt/equity ratio score it not favorable for BLBD, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 0.82
Altman-Z 6.79
ROIC/WACC3.86
WACC8.77%

2.3 Liquidity

BLBD has a Current Ratio of 1.23. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
BLBD has a worse Current ratio (1.23) than 85.16% of its industry peers.
A Quick Ratio of 0.56 indicates that BLBD may have some problems paying its short term obligations.
BLBD's Quick ratio of 0.56 is on the low side compared to the rest of the industry. BLBD is outperformed by 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.56

5

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 471.79%, which is quite impressive.
BLBD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.41% yearly.
Looking at the last year, BLBD shows a very strong growth in Revenue. The Revenue has grown by 26.17%.
Measured over the past years, BLBD shows a small growth in Revenue. The Revenue has been growing by 2.02% on average per year.
EPS 1Y (TTM)471.79%
EPS 3Y9.28%
EPS 5Y-8.41%
EPS Q2Q%229.63%
Revenue 1Y (TTM)26.17%
Revenue growth 3Y8.81%
Revenue growth 5Y2.02%
Sales Q2Q%15.38%

3.2 Future

The Earnings Per Share is expected to decrease by -16.90% on average over the next years. This is quite bad
The Revenue is expected to grow by 11.78% on average over the next years. This is quite good.
EPS Next Y171.21%
EPS Next 2Y72.29%
EPS Next 3Y-16.9%
EPS Next 5YN/A
Revenue Next Year18.79%
Revenue Next 2Y14.72%
Revenue Next 3Y8.58%
Revenue Next 5Y11.78%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.56 indicates a rather expensive valuation of BLBD.
Based on the Price/Earnings ratio, BLBD is valued a bit cheaper than 65.63% of the companies in the same industry.
When comparing the Price/Earnings ratio of BLBD to the average of the S&P500 Index (28.63), we can say BLBD is valued slightly cheaper.
The Price/Forward Earnings ratio is 16.94, which indicates a correct valuation of BLBD.
Based on the Price/Forward Earnings ratio, BLBD is valued a bit cheaper than 60.16% of the companies in the same industry.
BLBD's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.22.
Industry RankSector Rank
PE 18.56
Fwd PE 16.94

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BLBD.
80.47% of the companies in the same industry are more expensive than BLBD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.54
EV/EBITDA 12.76

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A cheap valuation may be justified as BLBD's earnings are expected to decrease with -16.90% in the coming years.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y72.29%
EPS Next 3Y-16.9%

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (6/21/2024, 7:00:01 PM)

After market: 53.82 0 (0%)

53.82

-0.81 (-1.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.74B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 18.56
Fwd PE 16.94
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.57%
ROE 75.8%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.72%
PM (TTM) 6.36%
GM 17.69%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.76
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.23
Quick Ratio 0.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)471.79%
EPS 3Y9.28%
EPS 5Y
EPS Q2Q%
EPS Next Y171.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.17%
Revenue growth 3Y8.81%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y